%0 Generic
%T Impact of Delayed-Dose Administration of USL255, an Extended-Release Topiramate Formulation (P3.257)
%A Anders, Bob
%A Lu, Qiang
%A Ludwig, Elizabeth
%A Clark, Annie
%I Ovid Technologies (Wolters Kluwer Health)
%@ 1526-632X
%@ 0028-3878
%K Neurology (clinical)
%D 2014
%C Ovid Technologies (Wolters Kluwer Health)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation